NASM Launches New Understanding Weight Loss Medications Course
Based Review of GLP-1/GIP Agonists for Fitness and Wellness ProfessionalsGilbert, AZ, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The ...
Daily19h
Elective Peri-Operative Management of Patients on GLP-1, GIP Agonists & SGLT-2 Inhibitors: Multidisciplinary Consensus Released
UK: A recent consensus statement from leading UK medical organizations-including the Association of Anaesthetists,the ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.
I’m a holistic doctor — 3 foods that mimic Ozempic and how they work
Looking for a natural alternative to GLP-1 drugs? Integrative medicine physician Dr. Taz Bhatia has shared three foods that ...
Blockbuster weight-loss drugs flood grey market, used without supervision: ‘This trend is triggering paralysis of gut,’ warn doctors
Tirzepatide, found in Mounjaro and Zepbound, mimics both GIP and GLP-1 hormones to activate insulin production. Semaglutide, ...